Progress towards in vivo use of siRNAs
MA Behlke - Molecular Therapy, 2006 - cell.com
RNA interference (RNAi) has become the method of choice to suppress gene expression in
vitro. It is also emerging as a powerful tool for in vivo research with over 90 studies …
vitro. It is also emerging as a powerful tool for in vivo research with over 90 studies …
Lipid nanoparticle delivery systems to enable mRNA-based therapeutics
SC Semple, R Leone, CJ Barbosa, YK Tam, PJC Lin - Pharmaceutics, 2022 - mdpi.com
The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2
infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of …
infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of …
Liposomes in ultrasonic drug and gene delivery
SL Huang - Advanced drug delivery reviews, 2008 - Elsevier
Liposome-based drug and gene delivery systems have potential for significant roles in a
variety of therapeutic applications. Recently, liposomes have been used to entrap gas and …
variety of therapeutic applications. Recently, liposomes have been used to entrap gas and …
Advances in the understanding of skin cancer: ultraviolet radiation, mutations, and antisense oligonucleotides as anticancer drugs
KV Laikova, VV Oberemok, AM Krasnodubets… - Molecules, 2019 - mdpi.com
Skin cancer has always been and remains the leader among all tumors in terms of
occurrence. One of the main factors responsible for skin cancer, natural and artificial UV …
occurrence. One of the main factors responsible for skin cancer, natural and artificial UV …
Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides
Synthetic oligodeoxynucleotides (ODN) containing CpG sequences are recognized as a
“danger” signal by the immune system of mammals. As a consequence, CpG ODN stimulate …
“danger” signal by the immune system of mammals. As a consequence, CpG ODN stimulate …
Targeting c-MYC in platinum-resistant ovarian cancer
JM Reyes-González, GN Armaiz-Peña… - Molecular cancer …, 2015 - AACR
The purpose of this study was to investigate the molecular and therapeutic effects of siRNA-
mediated c-MYC silencing in cisplatin-resistant ovarian cancer. Statistical analysis of …
mediated c-MYC silencing in cisplatin-resistant ovarian cancer. Statistical analysis of …
Cancer therapeutics: targeting the dark side of Myc
R Ponzielli, S Katz, D Barsyte-Lovejoy… - European journal of …, 2005 - Elsevier
The potent Myc oncoprotein plays a pivotal role as a regulator of tumorigenesis in numerous
human cancers of diverse origin. Experimental evidence shows that inhibiting Myc …
human cancers of diverse origin. Experimental evidence shows that inhibiting Myc …
The MYC oncogene as a cancer drug target
H Hermeking - Current cancer drug targets, 2003 - ingentaconnect.com
The universal deregulation of c-myc gene expression in tumor cells suggests that this
oncogene represents an attractive target for cancer therapeutic purposes. The same applies …
oncogene represents an attractive target for cancer therapeutic purposes. The same applies …
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN
S de Jong, G Chikh, L Sekirov, S Raney… - Cancer Immunology …, 2007 - Springer
Immunostimulatory oligodeoxynucleotides (ODN) containing cytosine-guanine (CpG) motifs
are powerful stimulators of innate as well as adaptive immune responses, exerting their …
are powerful stimulators of innate as well as adaptive immune responses, exerting their …
Liposomal formulations for nucleic acid delivery
I MacLachlan - Antisense Drug Technology, 2007 - api.taylorfrancis.com
Multilamellar vesicles (MLVs) are formed by the aqueous hydration of dried lipid films.
Typically hundreds of nanometers in diameter, they are large, complex structures containing …
Typically hundreds of nanometers in diameter, they are large, complex structures containing …